ADMA Biologics, Inc. (ADMA)
15.71
-0.83
(-5.02%)
USD |
NASDAQ |
Mar 05, 16:00
15.71
0.00 (0.00%)
After-Hours: 16:13
ADMA Biologics Cash from Investing (TTM) : -21.89M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Marker Therapeutics, Inc. | 0.00 |
| Arcutis Biotherapeutics, Inc. | -30.25M |
| CorMedix, Inc. | -312.03M |
| AtriCure, Inc. | -14.55M |
| Ligand Pharmaceuticals, Inc. | -377.32M |